Related Party Transactions (Tables)
|
12 Months Ended |
Mar. 31, 2024 |
|---|
| Related Party Transactions [Abstract] |
|
| Schedule of Major Related Parties and their Relationships |
The table below sets forth the major related parties and
their relationships with the Company as of March 31, 2022, 2023 and 2024:
| Name of related parties | | Relationship with the Company | | Nanjing Animal Pharmaceutical | | An equity investee of the Company until December, 2022 | | Wuhan Chunzhijin | | An equity investee of the Company | | Weishi Network | | An equity investee of the Company | | Beijing Petdog | | An available-for-sale debt investee that the Company has significant influence | Shanghai Guangcheng Information Technology (limited partnership)
(“Shanghai Guangcheng Information”) | | A company with a common director of the Company | | MERCHANT TYCOON LIMITED | | A shareholder of the Company | | SUPERB ORIGIN INTERNATIONAL LIMITED | | A shareholder of the Company | | Yingzhi (Lisa) Tang | | Senior management of the Company | | Yan Jiang | | Senior management of the Company | | Di (Jackie) Chen | | Senior management of the Company until July, 2021 | | Ying (Christina) Zhang | | Senior management of the Company until February, 2022 | | Fei Wang | | Senior management of the Company until April, 2022 | | Lijun Zhou | | Senior management of the Company until April, 2022 |
|
| Schedule of Related Party Transactions |
Details of related party transactions are as follows:
| | |
Year
Ended March
31, 2022 | | |
Year
Ended March
31,
2023 | | |
Year
Ended March
31,
2024 | |
| | |
RMB | | |
RMB | | |
RMB | |
| Online marketing and information services | |
| | |
| | |
| |
| | |
| | | |
| | | |
| | |
| Weishi Network | |
| 19 | | |
| - | | |
| - | |
| | |
| 19 | | |
| - | | |
| - | |
| Purchase of merchandise | |
| | |
| | |
| |
| | |
| | |
| | |
| |
| Weishi Network | |
| 1,582 | | |
| - | | |
| - | |
| Nanjing Animal Pharmaceutical | |
| 1,020 | | |
| 1,402 | | |
| 3,891 | |
| | |
| 2,602 | | |
| 1,402 | | |
| 3,891 | |
|
| Schedule of Loans Granted to Related Parties |
| | |
Year
Ended March
31, 2022 | | |
Year
Ended March
31, 2023 | | |
Year
Ended March
31, 2024 | |
| | |
RMB | | |
RMB | | |
RMB | |
| Loans granted to related parties | |
| | | |
| | | |
| | |
| | |
| | | |
| | | |
| | |
| Shanghai Guangcheng Information (a) | |
| 33,395 | | |
| - | | |
| - | |
| Wuhan Chunzhijin (b) | |
| 2,600 | | |
| 2,720 | | |
| 4,761 | |
| MERCHANT TYCOON LIMITED | |
| - | | |
| 100 | | |
| - | |
| Yingzhi (Lisa) Tang | |
| 1,750 | | |
| - | | |
| - | |
| Lijun Zhou | |
| 300 | | |
| - | | |
| - | |
| Yan Jiang | |
| 70 | | |
| - | | |
| - | |
| | |
| 38,115 | | |
| 2,820 | | |
| 4,761 | |
| (a) | In April 2021, the Company granted Shanghai Guangcheng Information a short-term loan with a total principal amount of RMB33.4 million (equivalent to USD 5 million), bearing an interest rate of 3.5% per annum. The loan was fully repaid by March 31, 2022. |
| (b) | The Company entered into a loan agreement with Wuhan Chunzhijin to provide Wuhan
Chunzhijin with an interest-free loan of up to RMB10 million, which will be repaid on demand. In March 2023, the company converted RMB3.4
million loan to Wuhan Chunzhijin into equity interest. (Detail refer to Note 11). |
|
| Schedule of Advances Provided to Related Parties |
| | |
Year
Ended March
31, 2022 | | |
Year
Ended March
31, 2023 | | |
Year
Ended March
31, 2024 | |
| | |
RMB | | |
RMB | | |
RMB | |
| Advances provided to related parties | |
| | |
| | |
| |
| | |
| | |
| | |
| |
| SUPERB ORIGIN INTERNATIONAL LIMITED (b) | |
| - | | |
| 5,497 | | |
| - | |
| Nanjing Animal Pharmaceutical (c) | |
| - | | |
| 350 | | |
| 5,413 | |
| | |
| - | | |
| 5,847 | | |
| 5,413 | |
| | |
| | | |
| | | |
| | |
| Loans granted from related parties | |
| | | |
| | | |
| | |
| | |
| | | |
| | | |
| | |
| Shanghai Guangcheng Information (a) | |
| 9,961 | | |
| - | | |
| - | |
| (a) | In April 2021, the Company obtained a total loan facility up to USD 5 million from Shanghai Guangcheng Information. During the year ended March 31, 2022, the Company drew down a total amount of USD 1.5 million (equivalent to RMB10.0 million) from the loan facility, with interest bearing at 3.5% per annum. The loan was fully repaid by March 31, 2022. |
| (b) | In January 2023, the Company made an advance payment of RMB 5.5 million to SUPERB ORIGIN INTERNATIONAL
LIMITED for the purchase of goods. As of March 31, 2023 and 2024, the balance of the advance payment was RMB 5.5 million and RMB 4.1 million
respectively, both of which are recorded as Prepayments to related parties. |
| (c) | During the years ended March 31, 2023, and 2024, the Company made advance payments totaling RMB 0.35 million
and RMB5.4 million, respectively, to Nanjing Animal Pharmaceutical for the purchase of goods. As of March 31, 2023, and 2024, there were
goods valued at RMB 2.0 million and Nil, respectively, which were recorded as Prepayments to related parties. |
|
| Schedule of Amounts Due from Related parties |
Amounts due from related parties
| | |
As of
March 31, | | |
As of
March 31, | | |
As of
March 31, | |
| | |
2022 | | |
2023 | | |
2024 | |
| | |
RMB | | |
RMB | | |
RMB | |
| Prepayments to related parties | |
| | |
| | |
| |
| | |
| | |
| | |
| |
| SUPERB ORIGIN INTERNATIONAL LIMITED | |
| - | | |
| 5,497 | | |
| 4,065 | |
| Nanjing Animal Pharmaceutical | |
| 1,650 | | |
| 2,000 | | |
| - | |
| Weishi Network | |
| 1,582 | | |
| 1,582 | | |
| 1,401 | |
| | |
| 3,232 | | |
| 9,079 | | |
| 5,466 | |
| Other receivables from related parties | |
| | | |
| | | |
| | |
| | |
| | | |
| | | |
| | |
| Wuhan Chunzhijin | |
| 7,594 | | |
| 2,988 | | |
| 5,658 | |
| | |
| | | |
| | | |
| | |
| Loans to related parties | |
| | | |
| | | |
| | |
| Yan Jiang | |
| 200 | | |
| 200 | | |
| 211 | |
| Fei Wang (a) | |
| 500 | | |
| - | | |
| - | |
| Lijun Zhou | |
| 200 | | |
| - | | |
| - | |
| Shanghai Guangcheng Information | |
| - | | |
| - | | |
| 27 | |
| MERCHANT TYCOON LIMITED | |
| - | | |
| 100 | | |
| - | |
| | |
| 900 | | |
| 300 | | |
| 238 | |
| (a) | In January 2021, the Company entered into a one-year loan
agreement with Fei Wang, for a principal amount of RMB0.5 million, bearing an interest rate of 4% per annum. This loan was pledged by
515,000 stock options owned by Fei Wang. In December 2022, the loan contract was renewed to December 2024 and was recorded as prepayments
and other current assets as of March 31, 2024. |
|
| Schedule of Amount Due To Related Parties |
Amounts due to related parties
| | |
As of
March 31, | | |
As of
March 31, | | |
As of
March 31, | |
| | |
2022 | | |
2023 | | |
2024 | |
| | |
RMB | | |
RMB | | |
RMB | |
| Trade payables to related parties | |
| | |
| | |
| |
| | |
| | | |
| | | |
| | |
| Nanjing Animal Pharmaceutical | |
| 219 | | |
| 471 | | |
| - | |
|